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98-а підсумкова наукова конференція професорсько-викладацького персоналу
БУКОВИНСЬКОГО ДЕРЖАВНОГО МЕДИЧНОГО УНІВЕРСИТЕТУ
As seen from the established microbiological regulations comparison in both standards are focused to 
determination of water fecal contamination. Amount of indicators in the Ukrainian normative document results from the 
characteristics of water sources in our country and that is rational.
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The problem of resistance to antibiotics is one of the most serious threats of the global health care [Wellington 
E. М. H. et all., 2013; Laxminarayan R. et all., 2013; Leibovici L. et all., 2016]. Antibiotic resistance can become a 
global cause of mortality in case new effective antibiotics are not found and supplied adequately [Amabile-Cuevas C.F., 
2015]. Scientists from many countries focuse their attention on the necessity to search new antimicrobial means, as only 
few new antibiotics are synthesized a year, while the rate of resistance to them increases very fast [Spellberg B. et all., 
2013; Sengupta S. et all., 2013]. For example, since the beginning of this century no more than 5 new antibiotics have 
been synthesized, that is rather unfavourable statistics considering the rates of resistance development of 
microorganisms to them.
One of the ways out is to intensify the elaboration and introducing new antimicrobial drugs [Feshchenko Yu.I., 
2009]. Therefore, the search of new antibiotics and modification of those already known with the aim to improve them 
is one of the main directions of modem medicine [Todosiychuk T.S. et al., 2011].
To study in vitro antimicrobial activity of new derivatives of 2,4-disubstitutive 3-(l-ary l-imidazole-5 - 
il)propen-l-ions and 2,4-disubstitutive 3-(l-aryl-imidazole-5-il)propane-l-ions.
To study antimicrobial properties 17 new derivatives of 2,4-disubstitutive 3-(l-ary l-imidazole-5-il)propen-l- 
ions and 2,4-disubstitutive 3-(l-aryl-imidazole-5-il)propane-l-ions were selected with the following general formula:
R2
derivatives 2,4-disubstitutive 3-(1 -aryl-imidazole-5-il)propen-1 -ions
derivatives 2,4-disubstitutive 3-(1 -aryl-imidazole-5-il)propane-1 -ions
Their antimicrobial properties were studied by means of common methods of two-time series dilution in a 
liquid nutrient medium and detection of minimal bacteriostatic and fungistatic concentrations (MBsC, MFsC), minimal 
bactericidal or fungicidal concentrations (MBcC, MFcC) of compounds concerning reference strains of gram-positive 
bacteria {Staphylococcus aureus ATCC 25923), gram-negative bacteria {Escherichia coli ATCC 25922) and yeast-like 
fungi {Candida albicans ATCC 885-653).
A part of the derivatives of 2,4-disubstitutive 3-(l-aryl-imidazole-5-il)propen-l-ions was not found to reveal 
any antimicrobial properties. For example, both minimal bacteriostatic or fungistatic (MBsC, MFsC) and bactericidal or 
fungicidal (MBcC, MFcC) concentrations of 2653, 2661 and 2664 compounds concerning reference-strains of gram- 
positive bacteria {Staphylococcus aureus ATCC 25923), gram-negative bacteria {Escherichia coli ATCC 25922) and 
yeast-like fungi {Candida albicans ATCC 885-653) are more than 1000 mcg/ml. At the same time, the compounds 2001 
and 2654 reveal moderate antibacterial and antifungal properties -  their MBsC and MFsC are on the level of 250 
mcg/ml, MBcC and MFcC - 500 mcg/ml. It should be noted that the rest of the compounds (2652, 2663 and 2810) do 
not possess antibacterial properties concerning Staphylococcus aureus ATCC 25923 (minimal bactericide 
concentrations of the compounds indicatedare more than 1000 mcg/ml), but they demonstrate a moderate antimicrobial 
activity concerning Escherichia coli ATCC 25922 and/or Candida albicans ATCC 885-653 (MBsC and MFsC are on 
the levels of 250 mcg/ml, MBcC and MFcC - 500 mcg/ml).
Higher antimicrobial activity was found in the derivatives of 2,4-disubstitutive 3-(l-aryl-imidazole-5- 
il)propane-l-ions as compared to the derivatives of 2,4-disubstitutive 3-(l-aryl-imidazole-5-il)propen-l-ions. Thus, 
minimal bacteriostatic concentration of the examined derivatives of 2,4-disubstitutive 3-(l-ary l-imidazole-5-il)propane-
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1-ions concerning gram-positive bacteria (Staphylococcus aureus ATCC 25923) was 62,5 -  250 mcg/ml. A little less 
antibacterial action of these compounds was found concerning Escherichia coli ATCC 25922 (MBsC for the majority 
of compounds is on the level of 125-250 mcg/ml). The compounds examined revealed lower anticandidosis activity -  
minimal fungistatic concentrations of the compounds concerning Candida albicans ATCC 885-653 were from 125 to 
500 mcg/ml. Minimal bactericidal and fungicidal (MBcC, MFcC) concentrations of the examined compounds 
concerning reference-strains were in the majority of cases on the level of 125-1000 mcg/ml.
The examined derivatives of 2,4-disubstitutive 3-(l-aryl-imidazole-5-il)propen-l-ions and 2,4-disubstitutive 3- 
(l-aryl-imidazole-5-il)propane-l-ions possess moderate antibacterial and antifungal activity. Higher antimicrobial 
activity was found in the derivatives of 2,4-disubstitutive 3-(l-aryl-imidazole-5-il)propane-l-ions as compared to the 
derivatives of 2,4-disubstitutive 3-(l-aryl-imidazole-5-il)propen-l-ions. Minimal bacteriostatic concentration of the 
examined derivatives of 2,4-disubstitutive 3-(l-aryl-imidazole-5-il)propane-l-ions concerning Staphylococcus aureus 
ATCC 25923 was 62,5 -  250 mcg/ml, Escherichia coli ATCC 25922 - 125-250 mcg/ml, and minimal fungistatic 
concentrations of the compounds concerning Candida albicans ATCC 885-653 were from 125 to 500 mcg/ml.
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The search of new biologically active substances in a number of quinolin-4-carbonic acid (cinchonine) 
derivatives is a very prospective area of investigation [Dubrovin A.N. et al., 2014]. Quinolinic nucleus is a wide-spread 
pharmacophore fragment. Quinolin-4-carbonic acid and its derivatives were studied more carefully than any other 
quinolinic acids, and the compounds with different biological activity were found among them [Skrobala V. et al., 
2013]. Quinoxidine is used in medical practical work as an antibacterial means, and antimicrobial activity is found in 
isopropylamide 2-(2,4-dinitrophenylhydrasino) cinchoninic acid [Novikov M.V., 2009].
Although despite a rather wide use of 4-quinolincarbonic acids, the potential of their studies has not been 
exhausted. For example, the derivatives of 2-(l-phenyl-3-aryl-l#-pyrazol-4-il)benzo[b]quinolin-4-carbonic acid are not 
studied completely.
To study in vitro antimicrobial properties of new derivatives of 2-(l-phenyl-3-aryl-l//-pyrazol-4- 
il)benzo[b]quinolin-4-carbonic acid.
35 derivatives of 2-(l-phenyl-3-aryl-l№pyrazol-4-il)benzo[b]quinolin-4-carbonic acid were selected for the 
study, of the common formula:
J-.'Й І 98-а підсумкова наукова конференція професорсько-викладацького персоналу
А БУКОВИНСЬКОГО ДЕРЖАВНОГО МЕДИЧНОГО УНІВЕРСИТЕТУ
OH
3-[(3-aryl)-1-phenyl-l№pyrazol-4-il]benzo[b]quinolin-l-carbonic acid, for example, were received in the 
following way. The mixture of 0,0011 mole aldehyde, 0,16 g (0,0011 mole) P-naphthylamine and 0,1 g (0,0011 mole) 
of pyruvic acid in 5 ml of methanol was boiled during 3 hours. The sediment obtained was filtered, washed in 5 ml of 
methanol and dried in the air.
To study antimicrobial properties of the compounds examined generally accepted methods of two-time series 
dilution in a liquid nutrient medium were used. The museum strains of gram-positive bacteria (Staphylococcus aureus 
ATCC 25923), gram-negative bacteria (Escherichia coli ATCC 25922) and yeast-like fungi (Candida albicans ATCC 
885-653) were used as test-objects. The following liquid nutrient medium was used: beef-extract broth (BEB) for 
bacteria, and Sabouraud's peptone agar for fungi.
A number of in vitro experiments proved that prevailing majority (82,86 %) of the compounds examined 
possess antimicrobial activity. Minimal bacteriostatic concentration of the majority of derivatives of 2-(l-phenyl-3-агу 1- 
l#-pyrazol-4-il)benzo[b]quinolin-4-carbonic acid is within the limits of 250-1000 mc/ml. The compounds examined 
manifested the concentrations indicated both concerning gram-positive S. aureus ATCC 25923, and gram-negative E. 
coli ATCC 25922.
The analysis of the dependence of antimicrobial activity of 2-(l-phenyl-3-aryl-l//-pyrazol-4- 
il)benzo[b]quinolin-4-carbonic acid derivatives and their chemical structure has found the following. The nature of aryl 
fragment substitute in the position of 3-pyrazol effects the activity of the compounds examined. The presence of
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